Implementation of the Fatty Liver Index in Primary Care (FLI-AP)

Consorci Sanitari de l'Alt Penedès i Garraf

Status: Enrolling

Conditions: Overweight and Obesity; Hepatic Steatosis

Treatments: Other: FLI

Study type: Interventional

Funder types: Other

Identifiers

NCT06363617

CSAPG-58

Details and patient eligibility

About

This trial aims to evaluate the impact on cardiovascular risk control in individuals in risk of being affected by hepatic steatosis through the implementation of a screening test (Fatty Liver Index) in Primary Care. Medical teams in a primary care center will be divided into 2 groups, with one group using the screening test in their clinical practice. The number of interventions on cardiovascular risk occurring in patients attended by each group of medical teams will be evaluated and compared.

Enrollment: 434 estimated patients

Sex: All

Ages: 14+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Men and women aged 14 years and older.
• Attended at the Basic Care Units (BCU) participating in the Primary Care Center Baix a Mar study.
• Intention to undergo medical follow-up at the study center.
• Body mass index ≥ 25.

Exclusion criteria

• Pregnant women
• Alcohol consumption habit (Standard Drink Unit (SDU); one SDU equals 10 grams of alcohol. Risky consumption is considered from 4 SDUs in men and 2 SDUs in women).
• Displaced patients not assigned to the study center.
• Patients classified as Advanced Chronic Care Model or Complex Chronic Patient.
• Participants diagnosed with any of the following pathologies: Chronic liver diseases, including hepatic steatosis; Dementia; Active oncological diseases
• Cognitive or affective pathology that limits the ability to collaborate with lifestyle interventions carried out at the center.
• Patients under the care of endocrinology specialists.
• Participation in another clinical trial involving an experimental intervention during the period of this trial.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

434 participants in 2 patient groups

FLI test implementation

Experimental group

Description:

A training session will be conducted for healthcare professionals on the risks of hepatic steatosis in patients with a body mass index (BMI) equal to or greater than 25. Additionally, professionals will be instructed in the use of the Fatty Liver Index (FLI) tool, validated for assessing the risk of steatosis. This tool will be implemented in the center's computer system, making it accessible via a link for the professionals receiving the intervention.

Treatment:

Other: FLI

control

No Intervention group

Description:

This group of healthcare professionals will continue with their usual clinical practice.